miR-101 Enhances Cisplatin-Induced DNA Damage Through Decreasing Nicotinamide Adenine Dinucleotide Phosphate Levels by Directly Repressing Tp53-Induced Glycolysis and Apoptosis Regulator Expression in Prostate Cancer Cells
Author:
Affiliation:
1. Department of Urology, Shandong Shanxian Central Hospital, Heze, People's Republic of China.
2. Department of Orthopedics, Shandong Shanxian Central Hospital, Heze, People's Republic of China.
Publisher
Mary Ann Liebert Inc
Subject
Cell Biology,Genetics,Molecular Biology,General Medicine
Link
http://www.liebertpub.com/doi/pdf/10.1089/dna.2016.3612
Reference28 articles.
1. TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
2. A Systematic Review of Randomized Controlled Trials on Oral Chinese Herbal Medicine for Prostate Cancer
3. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β
4. MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer
5. MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancers
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism;Non-coding RNA Research;2024-06
2. Inhibition of TIGAR Increases Exogenous p53 and Cisplatin Combination Sensitivity in Lung Cancer Cells by Regulating Glycolytic Flux;International Journal of Molecular Sciences;2022-12-16
3. Epigenetic Reprogramming of the Glucose Metabolic Pathways by the Chromatin Effectors During Cancer;Subcellular Biochemistry;2022
4. Structure, regulation, and biological functions of TIGAR and its role in diseases;Acta Pharmacologica Sinica;2021-01-28
5. Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect;Molecular Therapy - Oncolytics;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3